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Accuracy and Optimization of a Subcutaneous Insulin 
Model for Less Acute Critical Care Patients
INTRODUCTION
Extending safe, effective glycemic control to the general wards requires a simple approach using subcutaneous (SC) insulin. However, this
approach can increase relative risk compared to intravenous insulin due to the increased variability of SC insulin appearance. This poster
evaluates the accuracy of a SC plasma insulin model and optimizes its parameters.
RESULTS
CONCLUSION
The SC plasma insulin model used captures the dynamics of regular SC insulin well. However, there appears to be a positive bias leading to an overall 
median [IQR] residual error of -28.3 [-37 -19] mU/L. The optimized model reduced the RMS residual error by 20-70% for each patient with a median [IQR] 
residual error of -5.37 [-15 9.7] mU/L. The distinct inter- and intra- patient, and cohort variation seen in this data highlights the importance to of understanding 
how SC insulin appearance dynamics may be affected by the subject condition. 
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fRI = 0.597 fRI = 0.25
RMS Median[IQR] RMS Median[IQR]
Patient 1 31.3 -31.6 [-36 -26] 8.90 0.144 [-4.9 7.8]
Patient 2 36.2 -36.5 [-44 -29] 21.7 -24.2 [-28 -12]
Patient 3 26.6 -17.8 [-35 -11] 13.0 10.6 [3.9 15]
Patient 4 24.9 -23.6 [-27 -19] 12.1 4.26 [-12 10]
Patient 5 31.1 -22.8 [-33 -9.9] 24.8 -7.58 [-14 25]
Patient 6 34.9 -30.8 [-38 -22] 18.5 -13.0 [-23 -8.0]
Overall 31.1 -28.3 [-37 -19] 17.4 -5.37 [-15 9.7]
Model fit improved by 
20-70% for each patient 
by identifying fRI.
The original model value 
for fRI was found using 
data from 18 heathy male 
volunteers. 
This change in fRI thus 
reflects a distinct 
difference in SC insulin 
kinetics between healthy 
volunteers and critical 
care patients.
The reduction of fRI
suggests less of the 
injected SC insulin is 
appearing in critical care 
patients than would 
appear in a healthy 
individuals injected with 
the same SC insulin 
bolus. 
TABLE I.   SUMMARY OF SUBCUTANEOUS TRIAL PATIENT CHARACTERISTICS. DATA ARE SHOW AS
MEDIAN [IQR] WHERE APPROPRIATE
TABLE II.  FITTED VALUES OF
SUBCUTANEOUS INSULIN MODEL
CONSTANTS
TABLE III. RESIDUAL ERROR OF SC MEASURED – MODELLED PLASMA INSULIN. DATA PRESENTED
AS MEDIAN[IQR]. 
FIGURE I. MEASURED AND MODELLED PLASMA INSULIN DATA FOR
SC INSULIN USING FRI = 0.597AND FRI = 0.25 
